Investing.com - Gilead (NASDAQ:GILD) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Gilead announced earnings per share of $2.65 on revenue of $7.42B. Analysts polled by Investing.com anticipated EPS of $1.74 on revenue of $6.25B.
Gilead shares are up 15% from the beginning of the year, still down 8.21% from its 52 week high of $73.34 set on August 18. They are under-performing the Nasdaq 100 which is up 22.42% from the start of the year.
Gilead shares lost 3.07% in after-hours trade following the report.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar